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Abstract
A 35-year-old female presented with pain and swelling of the distal left radius. A diagnosis of Ewing sarcoma was
made and she underwent neoadjuvant chemotherapy and surgery. Macroscopic viable areas remained on the map
of the surgical specimen; as such, she was classified as a poor responder and received high dose adjuvant
chemotherapy. She remained disease-free for five years, until age 40. A vaginal polyp was then detected during a
routine gynaecologic examination. It was removed and histopathology revealed metastatic Ewing sarcoma.
To our knowledge, this is the first reported case of a vaginal metastasis of Ewing sarcoma.
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Introduction
Ewing sarcoma (ES) is a small blue round cell tumor
belonging to the Ewing Family Tumour (EFT) together
with Primary Neuroectodermal Tumour (PNET) and
ASKIN tumor (of the thoracic wall). Eight hundred and
ninety six cases have been reported in our institute
since 1982. Ewing sarcoma has a distinct predilection
for males and occurs in the first two decades of life in
more than 75 percent of cases [1,2].
Metastases are frequent [3] and are mostly pulmonary
and osseous, but can be found in various other
locations.
We present here the first description of a vaginal
metastasis of Ewing sarcoma.
Case Report
A 35 year-old woman with no significant medical his-
tory presented with pain and swelling of the left wrist
over the past year. A radiograph and computed tomo-
graphy scan revealed a lytic lesion of the distal left
radius (Figure 1), with soft tissue extension on MR
examination (Figure 2, 3).
A biopsy was performed and histological examination
revealed a typical Ewing sarcoma. The diagnosis was
confirmed by FISH analysis, which demonstrated the
translocation t (11, 22).
Staging revealed a solitary non-specific pulmonary
nodule of the inferior right lobe that did not change
with time and was not considered metastatic.
The patient underwent neoadjuvant chemotherapy and
resection and allograft of the distal radius. She was con-
sidered as poor responder as macroscopic areas
remained on the surgical specimen, but all margins were
free of disease. High dose chemotherapy was then
performed.
After completion of her treatment, it was followed up
as per protocol and remained disease-free.
Five years later, during a routine gynaecologic exam, a
vaginal polyp was found and removed. Histology
revealed a ES metastasis (Figure 4), as confirmed by the
characteristic translocation t(11, 22).(Figure 5). The rest
of the evaluation (CT and bone scintigraphy) was
normal.
No treatment has been undertaken.
Discussion
Ewing sarcoma (ES) represents approximately ten per-
cent[1] of primary malignant bone tumours and one
percent of soft tissue tumours. It tends to arise in the
diaphysis or metaphyseal-diaphyseal portion of long
bones, although any bone may be involved.
Frequently, the first symptoms are pain and swelling.
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evidence of metastasis. Lungs and bone are the main
metastatic locations.
Radiologically, an aggressive osteolytic lesion is com-
monly observed.
ES is characterized by a morphologically uniform
round cell proliferation with round nuclei containing
fine chromatin.
CD99 is expressed in nearly all ES and thereby is a
highly sensitive immunohistochemical marker. Several studies have confirmed a characteristic 11, 22
(q24, q12) chromosomal translocation in 85 percent of
the cases [3]; the translocation t (21, 22) and three even
rarer translocations (t (7, 22), t(2, 22) t(17, 22)) have
also been found.
Necrosis has a strong prognostic value [4]. High dose
chemotherapy is used in poor responders [5].
Figure 1 Initial evaluation. CT: lytic lesion with partial cortical
destruction.
Figure 2 Axial T1W MR image after contrast medium injection:
the soft tissue extension is well studied.
Figure 3 Sagital T1W MR image, after contrast medium
injection. Medullary and soft tissue extensions are well evaluated.
Figure 4 The metastasis is made of homogeneous small round
cells.
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and/or vulva in the literature[6]. A few cases of primary
neuro ectodermal tumors (PNET) in the pelvis have also
been reported [7].
Unusual metastasic locations have been described, for
example, the breast [8], myocardial muscle [9], paranasal
sinuses [10], iris [11]), and pancreas [12]. That explains
why, even if a second primary cannot be completely
excluded in our case, the probability of a metastasis is
much higher. To our knowledge, this is the first case
ever reported of a vaginal Ewing metastasis.
Conclusion
This case exemplifies the idea that every new lesion in a
patient with Ewing sarcoma should be considered as a
possible metastasis.
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Figure 5 Interphase FISH with the EWSR1 (22q12) break-apart
probe. Within a single nucleus fused red/green signals mark one
intact 22q12 region, whereas split red/green signals indicate the
presence of an EWSR1 gene rearrangement.
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